Related Articles
Impact of molecular subtypes on metastatic behavior and overall survival in patients with metastatic breast cancer: A single‑center study combined with a large cohort study based on the Surveillance, Epidemiology and End Results database
Effect of HER2 expression status on the prognosis of patients with HR<sup>+</sup>/HER2<sup>‑</sup> advanced breast cancer undergoing advanced first‑line endocrine therapy
Efficacy of lapatinib combined with capecitabine in patients with HER2‑positive metastatic breast cancer in a real‑world study
Impact of metastatic status on the prognosis of EGFR mutation‑positive non‑small cell lung cancer patients treated with first‑generation EGFR‑tyrosine kinase inhibitors
Baseline lymphopenia as prognostic factor in patients with metastatic breast cancer treated with palbociclib